1. Home
  2. TFSL vs PTCT Comparison

TFSL vs PTCT Comparison

Compare TFSL & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFSL
  • PTCT
  • Stock Information
  • Founded
  • TFSL 1938
  • PTCT 1998
  • Country
  • TFSL United States
  • PTCT United States
  • Employees
  • TFSL N/A
  • PTCT N/A
  • Industry
  • TFSL Savings Institutions
  • PTCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TFSL Finance
  • PTCT Health Care
  • Exchange
  • TFSL Nasdaq
  • PTCT Nasdaq
  • Market Cap
  • TFSL 3.7B
  • PTCT 3.7B
  • IPO Year
  • TFSL 2007
  • PTCT 2013
  • Fundamental
  • Price
  • TFSL $12.68
  • PTCT $50.34
  • Analyst Decision
  • TFSL Hold
  • PTCT Buy
  • Analyst Count
  • TFSL 1
  • PTCT 14
  • Target Price
  • TFSL $15.00
  • PTCT $63.57
  • AVG Volume (30 Days)
  • TFSL 282.0K
  • PTCT 939.9K
  • Earning Date
  • TFSL 07-29-2025
  • PTCT 08-07-2025
  • Dividend Yield
  • TFSL 8.95%
  • PTCT N/A
  • EPS Growth
  • TFSL 0.98
  • PTCT N/A
  • EPS
  • TFSL 0.28
  • PTCT 7.51
  • Revenue
  • TFSL $304,101,000.00
  • PTCT $1,772,758,000.00
  • Revenue This Year
  • TFSL $0.93
  • PTCT $121.50
  • Revenue Next Year
  • TFSL $4.05
  • PTCT N/A
  • P/E Ratio
  • TFSL $45.07
  • PTCT $6.72
  • Revenue Growth
  • TFSL 0.00
  • PTCT 91.12
  • 52 Week Low
  • TFSL $11.29
  • PTCT $28.72
  • 52 Week High
  • TFSL $15.00
  • PTCT $58.38
  • Technical
  • Relative Strength Index (RSI)
  • TFSL 37.08
  • PTCT 54.78
  • Support Level
  • TFSL $12.54
  • PTCT $49.47
  • Resistance Level
  • TFSL $13.42
  • PTCT $52.45
  • Average True Range (ATR)
  • TFSL 0.21
  • PTCT 1.54
  • MACD
  • TFSL -0.08
  • PTCT -0.09
  • Stochastic Oscillator
  • TFSL 15.91
  • PTCT 49.17

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: